arrow_back Back to App

Maternal and Infant Syphilis Prevention: New Guidelines for Health Programs

This act aims to improve maternal and child health by increasing access to syphilis screening and treatment within Medicaid and CHIP programs. This means more pregnant women and newborns will have the opportunity for early detection and treatment of this disease, potentially preventing severe health issues and deaths. The act seeks to reduce the number of congenital syphilis cases, which can lead to lifelong health problems for children.
Key points
Increased access to syphilis screening for pregnant women and infants under Medicaid and CHIP programs.
Improved guidelines for medical facilities on early detection and treatment of congenital syphilis.
Support for medical education and telehealth use to enhance care.
More screenings during the third trimester of pregnancy and at delivery to prevent complications.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HR_3866
Sponsor: Rep. Ciscomani, Juan [R-AZ-6]
Process start date: 2025-06-10
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Maternal and Infant Syphilis Prevention Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HR_3866.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-06-10.

What are the main provisions?

Key points include:

  • Increased access to syphilis screening for pregnant women and infants under Medicaid and CHIP programs.
  • Improved guidelines for medical facilities on early detection and treatment of congenital syphilis.
  • Support for medical education and telehealth use to enhance care.
  • More screenings during the third trimester of pregnancy and at delivery to prevent complications.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Ciscomani, Juan [R-AZ-6].

What is the latest detailed status?

The latest detailed status is: Introduced in House

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-22.

CATEGORIES

Health Family